Outpatient Oncology Infusion Market Size, Share and Industry Analysis Report by Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), Application (Lung Cancer, Liver Cancer, Breast Cancer, Prostate Cancer), By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy) and Mode (Intramuscular (IM), Intravenous (IV), Subcutaneous), Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022– 2030

Report Content

Chapter 1   Methodology

1.1    Methodology

1.2    Market definitions

1.3    Forecast parameters

1.4    Data sources

1.4.1    Secondary

1.4.1.1   Paid sources

1.4.1.2   Unpaid sources

1.4.2    Primary

Chapter 2   Executive Summary

2.1    Outpatient oncology infusion industry 360° synopsis, 2017 - 2030

2.1.1    Business trends

2.1.2    Product trends

2.1.3    Application trends

2.1.4    Therapy trends

2.1.5    Mode trends

2.1.6    Regional trends

Chapter 3   Outpatient Oncology Infusion Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2017 - 2030

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1   Recent technological advancements in infusion pumps

3.3.1.2   Rising prevalence of cancer across the globe

3.3.1.3   Surging government initiatives for cancer awareness

3.3.2    Industry pitfalls & challenges

3.3.2.1   High costs of cancer therapies

3.3.2.2   Safety concern associated with the cancer therapy

3.4    Growth potential analysis

3.4.1    By product

3.4.2    By application

3.4.3    By therapy

3.4.4    By mode

3.5    COVID-19 impact analysis

3.6    Porter’s analysis

3.7    Competitive landscape, 2021

3.8    PESTEL analysis

Chapter 4   Outpatient Oncology Infusion Market, By Product

4.1    Key segment trends

4.2    Infusion Pumps

4.2.1    Market size, by region, 2017 - 2030 (USD Million)

4.3    Intravenous Sets

4.3.1    Market size, by region, 2017 - 2030 (USD Million)

4.4    IV Cannulas

4.4.1    Market size, by region, 2017 - 2030 (USD Million)

4.5    Needleless Connectors

4.5.1    Market size, by region, 2017 - 2030 (USD Million)

Chapter 5   Outpatient Oncology Infusion Market, By Application

5.1    Key segment trends

5.2    Lung Cancer

5.2.1    Market size, by region, 2017 - 2030 (USD Million)

5.3    Liver Cancer

5.3.1    Market size, by region, 2017 - 2030 (USD Million)

5.4    Breast Cancer

5.4.1    Market size, by region, 2017 - 2030 (USD Million)

5.5    Prostate Cancer

5.5.1    Market size, by region, 2017 - 2030 (USD Million)

5.6    Other

5.6.1    Market size, by region, 2017 - 2030 (USD Million)

Chapter 6   Outpatient Oncology Infusion Market, By Therapy

6.1    Key segment trends

6.2    Chemotherapy

6.2.1    Market size, by region, 2017 - 2030 (USD Million)

6.3    Targeted Therapy

6.3.1    Market size, by region, 2017 - 2030 (USD Million)

6.4    Immunotherapy

6.4.1    Market size, by region, 2017 - 2030 (USD Million)

6.5    Hormonal Therapy

6.5.1    Market size, by region, 2017 - 2030 (USD Million)

Chapter 7   Outpatient Oncology Infusion Market, By Mode

7.1    Key segment trends

7.2    Intramuscular (IM)

7.2.1    Market size, by region, 2017 - 2030 (USD Million)

7.3    Intravenous (IV)

7.3.1    Market size, by region, 2017 - 2030 (USD Million)

7.4    Subcutaneous

7.4.1    Market size, by region, 2017 - 2030 (USD Million)

7.5    Others

7.5.1    Market size, by region, 2017 - 2030 (USD Million)

Chapter 8   Outpatient Oncology Infusion Market, By Region

8.1    Key regional trends

8.2    North America

8.2.1    Market size, by country, 2017 - 2030 (USD Million)

8.2.2    Market size, by product, 2017 - 2030 (USD Million)

8.2.3    Market size, by application, 2017 - 2030 (USD Million)

8.2.4    Market size, by therapy, 2017 - 2030 (USD Million)

8.2.5    Market size, by mode, 2017 - 2030 (USD Million)

8.2.6    U.S.

8.2.6.1   Market size, by product, 2017 - 2030 (USD Million)

8.2.6.2   Market size, by application, 2017 - 2030 (USD Million)

8.2.6.3   Market size, by therapy, 2017 - 2030 (USD Million)

8.2.6.4   Market size, by mode, 2017 - 2030 (USD Million)

8.2.7    Canada

8.2.7.1   Market size, by product, 2017 - 2030 (USD Million)

8.2.7.2   Market size, by application, 2017 - 2030 (USD Million)

8.2.7.3   Market size, by therapy, 2017 - 2030 (USD Million)

8.2.7.4   Market size, by mode, 2017 - 2030 (USD Million)

8.3    Europe

8.3.1    Market size, by country, 2017 - 2030 (USD Million)

8.3.2    Market size, by product, 2017 - 2030 (USD Million)

8.3.3    Market size, by application, 2017 - 2030 (USD Million)

8.3.4    Market size, by therapy, 2017 - 2030 (USD Million)

8.3.5    Market size, by mode, 2017 - 2030 (USD Million)

8.3.6    Germany

8.3.6.1   Market size, by product, 2017 - 2030 (USD Million)

8.3.6.2   Market size, by application, 2017 - 2030 (USD Million)

8.3.6.3   Market size, by therapy, 2017 - 2030 (USD Million)

8.3.6.4   Market size, by mode, 2017 - 2030 (USD Million)

8.3.7    UK

8.3.7.1   Market size, by product, 2017 - 2030 (USD Million)

8.3.7.2   Market size, by application, 2017 - 2030 (USD Million)

8.3.7.3   Market size, by therapy, 2017 - 2030 (USD Million)

8.3.7.4   Market size, by mode, 2017 - 2030 (USD Million)

8.3.8    France

8.3.8.1   Market size, by product, 2017 - 2030 (USD Million)

8.3.8.2   Market size, by application, 2017 - 2030 (USD Million)

8.3.8.3   Market size, by therapy, 2017 - 2030 (USD Million)

8.3.8.4   Market size, by mode, 2017 - 2030 (USD Million)

8.3.9    Spain

8.3.9.1   Market size, by product, 2017 - 2030 (USD Million)

8.3.9.2   Market size, by application, 2017 - 2030 (USD Million)

8.3.9.3   Market size, by therapy, 2017 - 2030 (USD Million)

8.3.9.4   Market size, by mode, 2017 - 2030 (USD Million)

8.4    Asia Pacific

8.4.1    Market size, by country, 2017 - 2030 (USD Million)

8.4.2    Market size, by product, 2017 - 2030 (USD Million)

8.4.3    Market size, by application, 2017 - 2030 (USD Million)

8.4.4    Market size, by therapy, 2017 - 2030 (USD Million)

8.4.5    Market size, by mode, 2017 - 2030 (USD Million)

8.4.6    Japan

8.4.6.1   Market size, by product, 2017 - 2030 (USD Million)

8.4.6.2   Market size, by application, 2017 - 2030 (USD Million)

8.4.6.3   Market size, by therapy, 2017 - 2030 (USD Million)

8.4.6.4   Market size, by mode, 2017 - 2030 (USD Million)

8.4.7    China

8.4.7.1   Market size, by product, 2017 - 2030 (USD Million)

8.4.7.2   Market size, by application, 2017 - 2030 (USD Million)

8.4.7.3   Market size, by therapy, 2017 - 2030 (USD Million)

8.4.7.4   Market size, by mode, 2017 - 2030 (USD Million)

8.4.8    India

8.4.8.1   Market size, by product, 2017 - 2030 (USD Million)

8.4.8.2   Market size, by application, 2017 - 2030 (USD Million)

8.4.8.3   Market size, by therapy, 2017 - 2030 (USD Million)

8.4.8.4   Market size, by mode, 2017 - 2030 (USD Million)

8.4.9    Australia

8.4.9.1   Market size, by product, 2017 - 2030 (USD Million)

8.4.9.2   Market size, by application, 2017 - 2030 (USD Million)

8.4.9.3   Market size, by therapy, 2017 - 2030 (USD Million)

8.4.9.4   Market size, by mode, 2017 - 2030 (USD Million)

8.5    Latin America

8.5.1    Market size, by country, 2017 - 2030 (USD Million)

8.5.2    Market size, by product, 2017 - 2030 (USD Million)

8.5.3    Market size, by application, 2017 - 2030 (USD Million)

8.5.4    Market size, by therapy, 2017 - 2030 (USD Million)

8.5.5    Market size, by mode, 2017 - 2030 (USD Million)

8.5.6    Brazil

8.5.6.1   Market size, by product, 2017 - 2030 (USD Million)

8.5.6.2   Market size, by application, 2017 - 2030 (USD Million)

8.5.6.3   Market size, by therapy, 2017 - 2030 (USD Million)

8.5.6.4   Market size, by mode, 2017 - 2030 (USD Million)

8.5.7    Mexico

8.5.7.1   Market size, by product, 2017 - 2030 (USD Million)

8.5.7.2   Market size, by application, 2017 - 2030 (USD Million)

8.5.7.3   Market size, by therapy, 2017 - 2030 (USD Million)

8.5.7.4   Market size, by mode, 2017 - 2030 (USD Million)

8.6    MEA

8.6.1    Market size, by country, 2017 - 2030 (USD Million)

8.6.2    Market size, by product, 2017 - 2030 (USD Million)

8.6.3    Market size, by application, 2017 - 2030 (USD Million)

8.6.4    Market size, by therapy, 2017 - 2030 (USD Million)

8.6.5    Market size, by mode, 2017 - 2030 (USD Million

8.6.6    South Africa

8.6.6.1   Market size, by product, 2017 - 2030 (USD Million)

8.6.6.2   Market size, by application, 2017 - 2030 (USD Million)

8.6.6.3   Market size, by therapy, 2017 - 2030 (USD Million)

8.6.6.4   Market size, by mode, 2017 - 2030 (USD Million)

8.6.7    Saudi Arabia

8.6.7.1   Market size, by product, 2017 - 2030 (USD Million)

8.6.7.2   Market size, by application, 2017 - 2030 (USD Million)

8.6.7.3   Market size, by therapy, 2017 - 2030 (USD Million)

8.6.7.4   Market size, by mode, 2017 - 2030 (USD Million)

Chapter 9   Company Profiles

9.1    Strategy dashboard, 2021

9.2    B. Braun Melsungen AG

9.2.1    Business overview

9.2.2    Financial data

9.2.3    Product landscape

9.2.4    Strategic outlook

9.2.5    SWOT analysis

9.3    Baxter

9.3.1    Business overview

9.3.2    Financial data

9.3.3    Product landscape

9.3.4    Strategic outlook

9.3.5    SWOT analysis

9.4    Becton, Dickinson, and Company

9.4.1    Business overview

9.4.2    Financial data

9.4.3    Product landscape

9.4.4    Strategic outlook

9.4.5    SWOT analysis

9.5    Fresenius Kabi

9.5.1    Business overview

9.5.2    Financial data

9.5.3    Product landscape

9.5.4    Strategic outlook

9.5.5    SWOT analysis

9.6    ICU Medical, Inc

9.6.1    Business overview

9.6.2    Financial data

9.6.3    Product landscape

9.6.4    Strategic outlook

9.6.5    SWOT analysis

9.7    IRadimed Corporation

9.7.1    Business overview

9.7.2    Financial data

9.7.3    Product landscape

9.7.4    Strategic outlook

9.7.5    SWOT analysis

9.8    Nipro Corporation

9.8.1    Business overview

9.8.2    Financial data

9.8.3    Product landscape

9.8.4    Strategic outlook

9.8.5    SWOT analysis

9.9    Terumo Corporation

9.9.1    Business overview

9.9.2    Financial data

9.9.3    Product landscape

9.9.4    Strategic outlook

9.9.5    SWOT analysis

9.10    Smiths Medical

9.10.1    Business overview

9.10.2    Financial data

9.10.3    Product landscape

9.10.4    Strategic outlook

9.10.5    SWOT analysis

9.11    Medtronic PLC

9.11.1    Business overview

9.11.2    Financial data

9.11.3    Product landscape

9.11.4    Strategic outlook

9.11.5    SWOT analysis

9.12    Roche Diagnostics

9.12.1    Business overview

9.12.2    Financial data

9.12.3    Product landscape

9.12.4    Strategic outlook

9.12.5    SWOT analysis

9.13    Teleflex, Inc.,

9.13.1    Business overview

9.13.2    Financial data

9.13.3    Product landscape

9.13.4    Strategic outlook

9.13.5    SWOT analysis
 

Data Tables

TABLE 1    Outpatient oncology infusion industry 360° synopsis, 2017-2030

TABLE 2    Global outpatient oncology infusion market, 2017-2030 (USD Million)

TABLE 3    Global outpatient oncology infusion market, by product, 2017-2030 (USD Million)

TABLE 4    Global outpatient oncology infusion market, by application, 2017-2030 (USD Million)

TABLE 5    Global outpatient oncology infusion market, by therapy, 2017-2030 (USD Million)

TABLE 6    Global outpatient oncology infusion market, by mode, 2017-2030 (USD Million)

TABLE 7    Global outpatient oncology infusion market, by region, 2017-2030 (USD Million)

TABLE 8    Industry impact forces

TABLE 9    Infusion pumps market size, by region, 2017-2030 (USD Million)

TABLE 10    Intravenous sets market size, by region, 2017-2030 (USD Million)

TABLE 11    IV cannulas market size, by region, 2017-2030 (USD Million)

TABLE 12    Needleless connectors market size, by region, 2017-2030 (USD Million)

TABLE 13    Lung cancer market size, by region, 2017-2030 (USD Million)

TABLE 14    Liver cancer market size, by region, 2017-2030 (USD Million)

TABLE 15    Breast cancer market size, by region, 2017-2030 (USD Million)

TABLE 16    Prostate cancer market size, by region, 2017-2030 (USD Million)

TABLE 17    Others market size, by region, 2017-2030 (USD Million)

TABLE 18    Chemotherapy market size, by region, 2017-2030 (USD Million)

TABLE 19    Targeted therapy market size, by region, 2017-2030 (USD Million)

TABLE 20    Immunotherapy market size, by region, 2017-2030 (USD Million)

TABLE 21    Hormonal therapy market size, by region, 2017-2030 (USD Million)

TABLE 22    Intramuscular (IM) market size, by region, 2017-2030 (USD Million)

TABLE 23    Intravenous (IV) market size, by region, 2017-2030 (USD Million)

TABLE 24    Others market size, by region, 2017-2030 (USD Million)

TABLE 25    North America outpatient oncology infusion market size, by country, 2017-2030 (USD Million)

TABLE 26    North America outpatient oncology infusion market size, by country, 2017-2030 (USD Million)

TABLE 27    North America outpatient oncology infusion market size, by product, 2017-2030 (USD Million)

TABLE 28    North America outpatient oncology infusion market size, by application, 2017-2030 (USD Million)

TABLE 29    North America outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)

TABLE 30    North America outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)

TABLE 31    U.S. outpatient oncology infusion market size, by product, 2017-2030 (USD Million)

TABLE 32    U.S. outpatient oncology infusion market size, by application, 2017-2030 (USD Million)

TABLE 33    U.S. outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)

TABLE 34    U.S. outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)

TABLE 35    Canada outpatient oncology infusion market size, by product, 2017-2030 (USD Million)

TABLE 36    Canada outpatient oncology infusion market size, by application, 2017-2030 (USD Million)

TABLE 37    Canada outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)

TABLE 38    Canada outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)

TABLE 39    Europe outpatient oncology infusion market size, by country, 2017-2030 (USD Million)

TABLE 40    Europe outpatient oncology infusion market size, by country, 2017-2030 (USD Million)

TABLE 41    Europe outpatient oncology infusion market size, by product, 2017-2030 (USD Million)

TABLE 42    Europe outpatient oncology infusion market size, by application, 2017-2030 (USD Million)

TABLE 43    Europe outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)

TABLE 44    Europe outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)

TABLE 45    Germany outpatient oncology infusion market size, by product, 2017-2030 (USD Million)

TABLE 46    Germany outpatient oncology infusion market size, by application, 2017-2030 (USD Million)

TABLE 47    Germany outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)

TABLE 48    Germany outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)

TABLE 49    UK outpatient oncology infusion market size, by product, 2017-2030 (USD Million)

TABLE 50    UK outpatient oncology infusion market size, by application, 2017-2030 (USD Million)

TABLE 51    UK outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)

TABLE 52    UK outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)

TABLE 53    France outpatient oncology infusion market size, by product, 2017-2030 (USD Million)

TABLE 54    France outpatient oncology infusion market size, by application, 2017-2030 (USD Million)

TABLE 55    France outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)

TABLE 56    France outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)

TABLE 57    Spain outpatient oncology infusion market size, by product, 2017-2030 (USD Million)

TABLE 58    Spain outpatient oncology infusion market size, by application, 2017-2030 (USD Million)

TABLE 59    Spain outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)

TABLE 60    Spain outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)

TABLE 61    Italy outpatient oncology infusion market size, by product, 2017-2030 (USD Million)

TABLE 62    Italy outpatient oncology infusion market size, by application, 2017-2030 (USD Million)

TABLE 63    Italy outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)

TABLE 64    Italy outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)

TABLE 65    Asia Pacific outpatient oncology infusion market size, by country, 2017-2030 (USD Million)

TABLE 66    Asia Pacific outpatient oncology infusion market size, by product, 2017-2030 (USD Million)

TABLE 67    Asia Pacific outpatient oncology infusion market size, by application, 2017-2030 (USD Million)

TABLE 68    Asia Pacific outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)

TABLE 69    Asia Pacific outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)

TABLE 70    Japan outpatient oncology infusion market size, by product, 2017-2030 (USD Million)

TABLE 71    Japan outpatient oncology infusion market size, by application, 2017-2030 (USD Million)

TABLE 72    Japan outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)

TABLE 73    Japan outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)

TABLE 74    China outpatient oncology infusion market size, by product, 2017-2030 (USD Million)

TABLE 75    China outpatient oncology infusion market size, by application, 2017-2030 (USD Million)

TABLE 76    China outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)

TABLE 77    China outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)

TABLE 78    India outpatient oncology infusion market size, by product, 2017-2030 (USD Million)

TABLE 79    India outpatient oncology infusion market size, by application, 2017-2030 (USD Million)

TABLE 80    India outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)

TABLE 81    India outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)

TABLE 82    Australia outpatient oncology infusion market size, by product, 2017-2030 (USD Million)

TABLE 83    Australia outpatient oncology infusion market size, by application, 2017-2030 (USD Million)

TABLE 84    Australia outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)

TABLE 85    Australia outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)

TABLE 86    Latin America outpatient oncology infusion market size, by country, 2017-2030 (USD Million)

TABLE 87    Latin America outpatient oncology infusion market size, by product, 2017-2030 (USD Million)

TABLE 88    Latin America outpatient oncology infusion market size, by application, 2017-2030 (USD Million)

TABLE 89    Latin America outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)

TABLE 90    Latin America outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)

TABLE 91    Brazil outpatient oncology infusion market size, by product, 2017-2030 (USD Million)

TABLE 92    Brazil outpatient oncology infusion market size, by application, 2017-2030 (USD Million)

TABLE 93    Brazil outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)

TABLE 94    Brazil outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)

TABLE 95    Mexico outpatient oncology infusion market size, by product, 2017-2030 (USD Million)

TABLE 96    Mexico outpatient oncology infusion market size, by application, 2017-2030 (USD Million)

TABLE 97    Mexico outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)

TABLE 98    Mexico outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)

TABLE 99    MEA outpatient oncology infusion market size, by country, 2017-2030 (USD Million)

TABLE 100    MEA outpatient oncology infusion market size, by product, 2017-2030 (USD Million)

TABLE 101    MEA outpatient oncology infusion market size, by application, 2017-2030 (USD Million)

TABLE 102    MEA outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)

TABLE 103    MEA outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)

TABLE 104    South Africa outpatient oncology infusion market size, by product, 2017-2030 (USD Million)

TABLE 105    South Africa outpatient oncology infusion market size, by application, 2017-2030 (USD Million)

TABLE 106    South Africa outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)

TABLE 107    South Africa outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)

TABLE 108    Saudi Arabia outpatient oncology infusion market size, by product, 2017-2030 (USD Million)

TABLE 109    Saudi Arabia outpatient oncology infusion market size, by application, 2017-2030 (USD Million)

TABLE 110    Saudi Arabia outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)

TABLE 111    Saudi Arabia outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)

TABLE 112    UAE outpatient oncology infusion market size, by product, 2017-2030 (USD Million)

TABLE 113    UAE outpatient oncology infusion market size, by application, 2017-2030 (USD Million)

TABLE 114    UAE outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)

TABLE 115    UAE outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
 

Charts & Figures

FIG. 1    Industry segmentation

FIG. 2    Global outpatient oncology infusion market, 2017 - 2030 (USD Million)

FIG. 3    Growth potential analysis, by product

FIG. 4    Growth potential analysis, by application

FIG. 5    Growth potential analysis, by therapy

FIG. 6    Growth potential analysis, by mode

FIG. 7    Porter’s analysis

FIG. 8    PESTEL analysis

FIG. 9    Key segment trends, by product

FIG. 10    Key segment trends, by application

FIG. 11    Key segment trends, by therapy

FIG. 12    Key segment trends, by mode

FIG. 13    Key regional trends

FIG. 14    Strategy dashboard, 2021